Latest Health News
- FDA Approves New Drug for Kids With Severe Immune DiseaseThe FDA has approved remestemcel-L, a new treatment for children age 2 months or older with steroid-refractory acute graft-versus-host disease (SR-aGVHD), a major complication of donor bone marrow transplantation.
- FDA Approves New Drug for Advanced Lung CancerThe FDA has approved a new drug called ensartinib for adults with a type of lung cancer called ALK-positive non-small-cell lung cancer (NSCLC).
- Feeling Blue? Holiday Lights Might Be the CureMental health issues, such as depression and substance use, often peak during the holidays, but research has shown that just looking at twinkling lights outside of people’s homes evokes feelings of friendliness and warmth.
- U.S. Sees Rise in Life Expectancy After Pandemic DeclineCOVID-19 continues to retreat from being a top cause of death in the U.S., and in turn, life expectancy last year rebounded further toward pre-pandemic longevity.
- Quitting Cannabis During Pregnancy: Your FAQs AnsweredPregnancy symptoms can trick you into thinking cannabis might help – but it could hurt. Here’s what to know about staying cannabis-free for nine months and beyond.
- New Findings Highlight Best Adult ADHD TreatmentsDo the same treatments that help children focus and manage hyperactivity and attention problems also work for adults with attention deficit hyperactivity disorder (ADHD)?
- FDA Approves Nemluvio for Atopic DermatitisThe FDA has approved Nemluvio for treating moderate to severe atopic dermatitis, a type of eczema, in people aged 12 or older.
- mRNA Lung Cancer Vaccine Could Be Revolutionary TreatmentA new vaccine to treat non-small-cell lung cancer is undergoing phase I trials and offering a potential breakthrough in immunotherapy.
- Nearly a Quarter of Americans Endured Chronic Pain Last YearNew CDC data shows that in a survey, 24% of adults said they had pain most days or every day during the past three months.
- FDA Approves Drug for Rare Adrenal Gland DisorderThe FDA has approved crinecerfont, marketed under the brand name Crenessity, a first-in-class oral drug for treating classic congenital adrenal hyperplasia (CAH), a rare genetic condition present from birth.
- Why Holiday Family Time Can Feel Like a Health HazardDoes your family make you sick at the holidays? We’re not just talking about catching a bug. It’s the emotional toll, which can unwrap physical and mental ailments.
- FDA Approves New Drug for Advanced Skin CancerThe FDA has approved cosibelimab (marketed under the brand name Unloxcyt), a new drug for adults with advanced cutaneous squamous cell carcinoma (CSCC), a type of skin cancer.
- Kids’ Flu Vaccination Rates Continue to Plummet This SeasonThe big drop in child flu vaccination rates last year appears to not be a blip. Just 37% of kids have gotten flu shots this year, according to new CDC data.
- The Bonus Protections of Routine VaccinesVaccination can bring more than just one unexpected benefit.
- Cervical Cancer Screening Made Simple with Self-Swab OptionMost women have stepped inside a bathroom at the doctor’s office to collect a urine sample for various tests. Now, they may also be asked to do a quick vaginal swab to be screened for cervical cancer.
- For Heart Health, Skip the Soda and Have Ice Cream InsteadThe choice between a scoop of ice cream or a bubbly sweet soda could make a difference in a person’s risk of serious problems with the heart and blood vessels like having an aneurysm or stroke.
- Is Drinking More Water Actually Healthy? Maybe.A new study review says increasing water intake could aid weight loss, help prevent kidney stones, and more. Here’s what to know.
- Feds Take Aim at Dry-Cleaning Chemicals, Red Dye No. 3Health concerns have prompted the Environmental Protection Agency to ban certain chemicals used for dry cleaning and for making everyday products like glue.
- Your Guide to COVID Vaccines for 2024-2025Here’s what to know about the 2024-2025 vaccines — what’s available, how the updated versions are tested, how well each protects you, side effects and other safety information, the best time to get them, and where.
- FDA Approves Drug for Aggressive Small-Cell Lung CancerThe FDA has approved the drug durvalumab for adults with limited-stage small-cell lung cancer (LS-SCLC) whose disease hasn’t gotten worse after getting platinum-based chemo and radiation at the same time.
- Whooping Cough and Newborns: How to Set Boundaries With VisitorsEveryone wants to meet (and snuggle!) the new baby. How can parents let loved ones know precautions need to be taken so Baby doesn’t get sick?
- U.S. Life Expectancy to Fall Behind That of Global Peers by 2050Life expectancy in the United States is improving a little, but not as much as that of many other high-income and some middle-income nations, a new study says.
- Ulcerative Colitis: New Medications, New Hope for RemissionSeveral new drugs will soon be available that show greater effectiveness at treating -- and possible ending -- ulcerative colitis.
- What Will Be the Next Ozempic?Ozempic and other GLP-1 drugs have surged in popularity, dominating U.S. medication spending in 2023 for their effectiveness in managing diabetes and promoting weight loss. As demand grows, promising new drugs like tirzepatide and retatrutide—offering even greater weight-loss potential—could become the “next Ozempic,” though high costs, side effects, and limited access remain significant challenges.
- FDA Approves New Drug for Lung and Pancreatic CancersThe FDA has granted accelerated approval to zenocutuzumab, a new drug for adults with advanced non-small-cell lung cancer (NSCLC) or pancreatic cancer.
Recommended